Latest News

Echo Therapeutics Launches Corporate Twitter Account and Facebook Page

FRANKLIN, Mass. Jan. 25, 2011

Echo joins other medical device companies who are utilizing social media to provide online communities and individuals with faster and more direct access to credible health information, resources, news, and events.

Patrick T. Mooney

About Echo Therapeutics

Echo Therapeutics is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units.  Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking Statements

December 31, 2009

For More Information:

Patrick T. Mooney, M.D.

Media: Richard Stern

Chairman and Chief Executive Officer

Stern & Co.

(508) 530-0329

(212) 888-0044

Connect With Us:

SOURCE Echo Therapeutics, Inc.

Leave a comment

seks shop - izolasyon
basic theory test book basic theory test